Apyx Medical Corporation (APYX) posted a Q4 2025 net loss of $0.03 per share. The company generated $19.2M in revenue for the quarter. The energy technology company designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
Apyx Medical operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company serves healthcare providers with its proprietary energy-based surgical and cosmetic solutions.
A detailed analysis of Apyx Medical Corporation’s quarter follows shortly on AlphaStreet.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.